Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials
Thomas P. Lodise, Antonio R. Anzueto, David J. Weber, Andrew F. Shorr, Min Yang, Alexander Smith, Qi Zhao, Xingyue Huang, Thomas M. File
Dive into the research topics of 'Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials'. Together they form a unique fingerprint.